Histologic Outcomes of Treatment With Mirikizumab and Their Association With Endoscopic Outcomes in Patients With Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial
Clin. Gastroenterol. Hepatol. 2024 Sep 01;22(9)1878-1888.e10, F Magro, M Protic, G De Hertogh, LS Chan, P Pollack, V Jairath, H Carlier, E Hon, BG Feagan, N Harpaz, R Pai, W ReinischFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.